| Page 1489 | Kisaco Research
 

Rich Jones

EVP & Executive Director
Heritage Cares

Rich Jones

EVP & Executive Director
Heritage Cares

Rich Jones

EVP & Executive Director
Heritage Cares
 

Luba Greewood

Co-Founder & Board Member
LUCA Biologics

Luba Greewood

Co-Founder & Board Member
LUCA Biologics

Luba Greewood

Co-Founder & Board Member
LUCA Biologics
 

Ally Crays

Youth Advisory Council Chair
PERIOD

Ally Crays

Youth Advisory Council Chair
PERIOD

Ally Crays

Youth Advisory Council Chair
PERIOD
 

Yifat Merbl

Weizmann Institute

Yifat Merbl

Weizmann Institute

Yifat Merbl

Weizmann Institute
 

Christina Woo

Harvard University

Christina Woo

Harvard University

Christina Woo

Harvard University
 

Tom Shepherd

Captor Therapeutics

Dr. Tom Shepherd is Chief Executive Officer of Captor Therapeutics, a drug discovery company focused on Targeted Protein Degradation listed on the Warsaw Stock Exchange since its IPO in 2021, with laboratory facilities in Poland and in Switzerland.

 

Tom Shepherd

Captor Therapeutics

Tom Shepherd

Captor Therapeutics

Dr. Tom Shepherd is Chief Executive Officer of Captor Therapeutics, a drug discovery company focused on Targeted Protein Degradation listed on the Warsaw Stock Exchange since its IPO in 2021, with laboratory facilities in Poland and in Switzerland.

 

Tom has a Ph.D. in Biochemistry from the University of Strathclyde in his native Scotland. Following an early career in the Medical Department of Novartis, he has since primarily worked in Business Development and General Management roles internationally in drug discovery companies in the UK, California, France, Australia, and Switzerland, including with Bausch-Health and Kymab, prior to joining Captor Therapeutics in Poland in 2019.